Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
In Acute Topics in Sport Nutrition , 59 , 135-142
Inhibition of Fatty Acid Oxidation Modulates Immunosuppressive Functions of Myeloid-Derived Suppressor Cells and Enhances Cancer Therapies
Presented for research literature review only Nasca C et al
However, the molecular mechanisms underlying these interactions require further characterisation in future research
Batch: GF-KLOW-B242 Key analytical results include: GHK-Cu Assay: 62.1 mg TB-500 Assay: 14.96 mg BPC-157 Assay: 13.63 mg KPV Assay: 10.09 mg GHK-Cu Purity: greater than 99.8 percent TB-500 Purity: 99.8 percent BPC-157 Purity: 99.4 percent KPV Purity: greater than 99.8 percent GHK-Cu Identification RT: 0.992 TB-500 Identification RT: 0.983 BPC-157 Identification RT: 0.981 KPV Identification RT: 0.993 Molecular Ion Mass Identification (GHK-Cu): confirmed Molecular Ion Mass Identification (TB-500): confirmed Molecular Ion Mass Identification (BPC-157): confirmed Molecular Ion Mass Identification (KPV): confirmed Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Product Overview Klow 80 mg is a multi-peptide research blend studied in controlled laboratory environments focused on peptide-mediated signalling pathways and molecular regulatory systems
There are no questions yet for this product.
